Despite the reduction of GLP-1 secretion, the glucose-lowering action of GLP-1 are preserved in patients with type 2 diabetes [44, 45], as well as the actions of GLP-1 on inhibition of gastric emptying [46]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.